Search

Search Constraints

You searched for: Author/Creator Devine, Steven M.

Search Results

1. A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma. Issue 4 (April 2015)

3. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014)

4. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014)

5. Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma. Issue 8 (August 2013)

6. Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. Issue 6 (10th December 2019)

7. High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. (28th February 2017)

8. Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome. (December 2021)

9. Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant. Issue 4 (April 2015)

10. Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. Issue 9 (1st September 2016)